I agree that this site is using cookies. You can find further informations here.
X
Folgori, F
31  results:
OpenAccess-fulltext X
Search for persons X
?
1

Standardising neonatal and paediatric antibiotic clinical t..:

Folgori, Laura ; Lutsar, Irja ; Standing, Joseph F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955510/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
2

Hepatitis C Virus-Multispecific T-Cell Responses without Vi..:

Abdelwahab, Sayed F ; Zakaria, Zainab ; Sobhy, Maha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346335.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
3

GRAd-COV2 vaccine provides potent and durable humoral and c..:

Capone S ; Fusco F. M ; Milleri S...
info:eu-repo/semantics/altIdentifier/pmid/37315558.  , 2023
Link: https://hdl.handle.net/1..
 
?
4

Adenovirus vectors activate Vδ2+ γδT cells in a type I inte..:

Provine, NM ; Amini, A ; Garner, LC...
doi:10.1002/eji.202149367.  , 2022
Link: https://doi.org/10.1002/..
 
?
5

The Role of Virulence Factors in Neonatal Sepsis Caused by ..:

Barcellini, L ; Ricci, G ; Bresesti, I...
https://openaccess.sgul.ac.uk/id/eprint/115067/1/ijms-23-11930-v2.pdf.  , 2022
Link: https://openaccess.sgul...
 
?
6

Antibiotic Susceptibility, Virulome and Clinical Outcomes i..:

Folgori, L ; Di Carlo, D ; Commandatore, F...
https://openaccess.sgul.ac.uk/id/eprint/113328/6/antibiotics-10-00706-v2.pdf.  , 2021
Link: https://openaccess.sgul...
 
?
7

Antibiotic susceptibility, virulome, and clinical outcomes ..:

Folgori L ; Di Carlo D ; Comandatore F...
info:eu-repo/semantics/altIdentifier/pmid/34208220.  , 2021
Link: http://hdl.handle.net/11..
 
?
8

MHC class II invariant chain–adjuvanted viral vectored vacc..:

Esposito, I ; Cicconi, P ; D'Alise, AM...
doi:10.1126/scitranslmed.aaz7715.  , 2020
Link: https://doi.org/10.1126/..
 
?
9

Characterizing Hepatitis C Virus–Specific CD4+ T Cells Foll..:

Hartnell, F ; Esposito, I ; Swadling, L...
https://discovery.ucl.ac.uk/id/eprint/10119596/1/hartnell2020.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
10

MHC class II invariant chain-adjuvanted viral vectored vacc..:

Esposito, I ; Cicconi, P ; D'Alise, AM...
https://discovery.ucl.ac.uk/id/eprint/10103171/1/MHC%20class%20II%20invariant%20chain-adjuvanted%20viral%20vectored%20vaccines%20%28before%20galley%29.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
11

Optimising T cell (re)boosting strategies for adenoviral an..:

Capone, S ; Brown, A ; Hartnell, F...
https://discovery.ucl.ac.uk/id/eprint/10113423/1/s41541-020-00240-0.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
12

MAIT cell activation augments adenovirus vector vaccine imm..:

Provine, N ; Amini, A ; Garner, L...
doi:10.1126/science.aax8819.  , 2020
Link: https://doi.org/10.1126/..
 
?
13

Adenoviral vaccine targeting multiple neoantigens as strate..:

D'Alise A. M ; Leoni G ; Cotugno G...
info:eu-repo/semantics/altIdentifier/pmid/31217437.  , 2019
Link: http://hdl.handle.net/23..
 
?
14

A Novel Vaccine Strategy Employing Serologically Different ..:

Hartnell, F ; Brown, A ; Capone, S...
https://discovery.ucl.ac.uk/id/eprint/10078774/1/A%20Novel%20Vaccine%20Strategy%20Employing%20Serologically%20Different%20Chimpanzee%20Adenoviral%20Vectors%20for%20the%20Prevention%20of%20HIV-1%20and%20HCV.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
15

A novel vaccine strategy employing serologically different ..:

Hartnell, F ; Brown, A ; Capone, S...
doi:10.3389/fimmu.2018.03175.  , 2019
Link: https://doi.org/10.3389/..
 
1-15